收费全文 | 46885篇 |
免费 | 3445篇 |
国内免费 | 164篇 |
耳鼻咽喉 | 701篇 |
儿科学 | 1084篇 |
妇产科学 | 712篇 |
基础医学 | 5724篇 |
口腔科学 | 777篇 |
临床医学 | 5313篇 |
内科学 | 9037篇 |
皮肤病学 | 643篇 |
神经病学 | 4125篇 |
特种医学 | 1888篇 |
外国民族医学 | 3篇 |
外科学 | 8118篇 |
综合类 | 795篇 |
现状与发展 | 1篇 |
一般理论 | 32篇 |
预防医学 | 3716篇 |
眼科学 | 994篇 |
药学 | 3542篇 |
1篇 | |
中国医学 | 76篇 |
肿瘤学 | 3212篇 |
2023年 | 283篇 |
2022年 | 408篇 |
2021年 | 1230篇 |
2020年 | 650篇 |
2019年 | 1209篇 |
2018年 | 1426篇 |
2017年 | 1025篇 |
2016年 | 1041篇 |
2015年 | 1276篇 |
2014年 | 1872篇 |
2013年 | 2378篇 |
2012年 | 3606篇 |
2011年 | 3860篇 |
2010年 | 2137篇 |
2009年 | 1803篇 |
2008年 | 3106篇 |
2007年 | 3425篇 |
2006年 | 3246篇 |
2005年 | 3095篇 |
2004年 | 2712篇 |
2003年 | 2704篇 |
2002年 | 2403篇 |
2001年 | 343篇 |
2000年 | 224篇 |
1999年 | 349篇 |
1998年 | 505篇 |
1997年 | 345篇 |
1996年 | 312篇 |
1995年 | 308篇 |
1994年 | 267篇 |
1993年 | 230篇 |
1992年 | 168篇 |
1991年 | 142篇 |
1990年 | 141篇 |
1989年 | 163篇 |
1988年 | 149篇 |
1987年 | 130篇 |
1986年 | 110篇 |
1985年 | 143篇 |
1984年 | 151篇 |
1983年 | 137篇 |
1982年 | 172篇 |
1981年 | 147篇 |
1980年 | 166篇 |
1979年 | 86篇 |
1978年 | 94篇 |
1977年 | 68篇 |
1976年 | 57篇 |
1975年 | 58篇 |
1974年 | 44篇 |
Female Genital mutilation/cutting (FGM/C) is associated with enduring psychiatric complications. In this study, we investigate the rates of co-morbid abuses and polyvictimization experienced by survivors of FGM/C. This is a sub-analysis of a cohort study examining the patient population at the EMPOWER Center for Survivors of Sex Trafficking and Sexual Violence in New York City. A retrospective chart-review of electronic medical records was conducted for all consenting adult patients who had FGM/C and had an intake visit between January 16, 2014 and March 6, 2020. Of the 80 participants, ages ranged from 20 to 62 years with a mean of 37.4 (SD?=?9.1) years. In addition to FGM/C, participants were victims of physical abuse (43; 53.8%), emotional abuse (35; 43.8%), sexual abuse (35; 43.8%), forced marriage (20; 25%), child marriage (13; 16.3%), and sex trafficking (1; 1.4%). There was a high degree of polyvictimization, with 41 (51.2%) experiencing 3 or more of the aforementioned abuses. Having FGM/C on or after age 13 or having a higher total abuse score was also found to be strong predictors of depression and PTSD. The high rates of polyvictimization among survivors of FGM/C are associated with development of depression and PTSD. Despite co-morbid abuses, patients still attribute substantial psychiatric symptoms to their FGM/C. Health care providers should understand the high risk of polyvictimization when caring for this patient population.
相似文献Objective
Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.Methods
From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.Results
Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).Conclusions
Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes. 相似文献Methods: A systematic literature search was performed to identify relevant randomized controlled trials (RCTs). Key outcomes of interest were clinical response (CD activity index [CDAI] reduction of 100 points; CDAI-100) and remission (CDAI score under 150 points; CDAI < 150). A treatment sequence Bayesian NMA was conducted to account for the re-randomization of patients based on different clinical definitions, the lack of similarity of the common comparator for each trial and the full treatment pathway from the induction phase onwards.
Results: Thirteen RCTs were identified. Ustekinumab 90?mg q8w was associated with statistically significant improvement in clinical response relative to placebo and vedolizumab 300?mg. For clinical remission, ustekinumab 90?mg q8w was associated with statistically significant improvement relative to placebo and vedolizumab 300?mg q8w. Findings from sub-population analyses had similar results but were not statistically significant.
Conclusions: The NMA suggest that ustekinumab is associated with the highest likelihood of reaching response or remission at 1?year compared with placebo, adalimumab and vedolizumab. Results should be interpreted with caution because this is a novel methodology; however, the treatment sequence analysis may be the most methodologically sound analysis to derive estimates of comparative efficacy in CD in the absence of head-to-head evidence. 相似文献